152 related articles for article (PubMed ID: 9577285)
1. Cardiac effects of short course dexamethasone in preterm infants.
Skelton R; Gill AB; Parsons JM
Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F133-7. PubMed ID: 9577285
[TBL] [Abstract][Full Text] [Related]
2. Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial.
Zecca E; Papacci P; Maggio L; Gallini F; Elia S; De Rosa G; Romagnoli C
J Clin Pharmacol; 2001 Oct; 41(10):1075-81. PubMed ID: 11583475
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of dexamethasone in the preterm infant.
Evans N
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F25-30. PubMed ID: 8117123
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants.
Israel BA; Sherman FS; Guthrie RD
Am J Perinatol; 1993 Jul; 10(4):307-10. PubMed ID: 8397569
[TBL] [Abstract][Full Text] [Related]
5. A three year follow up of preterm infants after moderately early treatment with dexamethasone.
Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F55-8. PubMed ID: 12091294
[TBL] [Abstract][Full Text] [Related]
6. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
Odd DE; Armstrong DL; Teele RL; Kuschel CA; Harding JE
J Paediatr Child Health; 2004; 40(5-6):282-9. PubMed ID: 15151582
[TBL] [Abstract][Full Text] [Related]
8. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
Bloomfield FH; Knight DB; Harding JE
J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
[TBL] [Abstract][Full Text] [Related]
9. Cardiac effects of dexamethasone in very low birth weight infants.
Bensky AS; Kothadia JM; Covitz W
Pediatrics; 1996 Jun; 97(6 Pt 1):818-21. PubMed ID: 8657520
[TBL] [Abstract][Full Text] [Related]
10. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants.
Romagnoli C; Zecca E; Vento G; De Carolis MP; Papacci P; Tortorolo G
Intensive Care Med; 1999 Jul; 25(7):717-21. PubMed ID: 10470576
[TBL] [Abstract][Full Text] [Related]
11. Effects of short-term dexamethasone treatment on collagen synthesis and degradation markers in preterm infants with developing lung disease.
Saarela T; Risteli J; Koivisto M
Acta Paediatr; 2003 May; 92(5):588-94. PubMed ID: 12839290
[TBL] [Abstract][Full Text] [Related]
12. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
[TBL] [Abstract][Full Text] [Related]
13. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
Schrod L; Neuhaus T; Horwitz AE; Speer CP
Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone and hypertension in preterm infants.
Greenough A; Emery EF; Gamsu HR
Eur J Pediatr; 1992 Feb; 151(2):134-5. PubMed ID: 1537356
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
[TBL] [Abstract][Full Text] [Related]
16. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial.
Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G
Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659
[TBL] [Abstract][Full Text] [Related]
17. High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.
Cranefield DJ; Odd DE; Harding JE; Teele RL
Pediatr Radiol; 2004 Feb; 34(2):138-42. PubMed ID: 14624322
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone treatment and fluid balance in preterm infants at risk for chronic lung disease.
Bos AF; van Asselt WA; Okken A
Acta Paediatr; 2000 May; 89(5):562-5. PubMed ID: 10852193
[TBL] [Abstract][Full Text] [Related]
19. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
Mieskonen S; Eronen M; Malmberg LP; Turpeinen M; Kari MA; Hallman M
Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
